New drug might increase the life of patients with a certain type of aggressive breast cancer
New drug gives hope for metastatic triple-negative breast cancer - science news articles with summaries

Triple-negative breast cancer is an aggressive disease for which the typical treatment is chemotherapy. Currently a new drug is being developed for the disease and the first clinical trial gave promising results.

The drug, sacituzumab govitecan is smartly designed to deliver toxins directly to tumor cells. It is made by putting together an antibody that recognizes the cancer cells and the metabolite of an established chemotherapy drug (irinotecan).

The drug was tested on 108 women and 33% of them responded. The drug increased the time for cancer progression, thus prolonging the life of patients compared to other drugs (it did not cure the disease). There were side effects, but fewer than traditional therapy.

Read the full story: Columbia University
Scientific publication: New England Journal of Medicine